Affiliation:
1. National Research Tomsk Polytechnic University; Tomsk Regional Oncology Dispensary
2. State Research Center – Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia
3. National Research Tomsk Polytechnic University
4. Tomsk Regional Oncology Dispensary
Abstract
Objective. To determine the most effective irradiation regimen (total dose and dose per fraction) for hypofractionated treatment for prostate carcinomas according the TCP/NTCP radiobiological criteria.Material and methods. Using the tomographic information of five patients with low-risk prostate adenocarcinoma as an example, the authors devised dosimetric radiation therapy plans using the volumetric modulated arc therapy (VMAT) procedure. They considered the range of total doses of 33.5 to 38 Gy administered in 4 and 5 fractions. Based on the equivalent uniform dose concept proposed by A. Niemierko and on the computed differential dose volume histograms, the investigators modeled local tumor control probability (TCP) values, by taking into account the uncertainties of main radiobiological parameters, and estimated normal tissue complication probabilities (NTCP) for the anterior rectal wall as the organ most at risk of irradiation. An effective dosimetric plan was selected according to the UTCP criterion and the probability of complication-free tumor control, i.e. TCP (1 – NTCP).Results. The results of modeling the UTCP criterion show that with a higher total dose, the TCP value increases and so does the NTCP value, therefore the optimal radiation therapy plans are to irradiate with a total dose of 34 Gy over 4 fractions or with a dose of 36–37 Gy over 5 fractions. The difference between the fractionation regimens is that the UTCP value is achieved with a higher TCP value over 4 fractions and with a lower load on the rectal wall over 5 fractions.Conclusion. The choice of a specific fractionation regimen should be determined from the calculated values of differential dose volume histograms for each patient, as well as from radiobiological criteria, such as TCP, NTCP and UTCP.
Reference20 articles.
1. Lo S.S., Teh B.S., Lu J.J., Schefter T.E. (Eds.). Stereotactic body radiation therapy. Berlin Heidelberg: Springer-Verlag; 2012.
2. Kharchenko V.P., Klepper L.Ya., Panyshin G.А., Sotnikova V.М., Datsenko P.V. Mathematical simulation of Hodgkin lymphoma probability dependence on total dose. Meditsinskaya Fizika (Medical Physics).2005; 4 (28): 28–35 (in Russ.).
3. Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 2008; 18 (4): 234–9. DOI: 10.1016/j.semradonc.2008.04.004
4. Li X.A., Alber M., Deasy J.O., Jackson A., Jee K.W., Marks L.B. et al. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med. Phys. 2012; 39 (3): 1386–409. DOI: 10.1118/1.3685447
5. National Radiotherapy Implementation Group Report. Stereotactic Body Radiotherapy Clinical Review of the Evidence for SBRT. NHS. National Cancer Action Team. Part of the National Cancer Programme. 2010: 13–25. Available at: http://www.academia.edu/978819/National_Radiotherapy_Implementation_Group_Report_Stereotactic_Body_Radiotherapy_Clinical_Review_of_the_Evidence_for_SBRT (accessed October 14, 2019).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献